Withuspharmaceutical Valuation
| 330350 Stock | KRW 6,410 50.00 0.77% |
At this time, the company appears to be overvalued. Withuspharmaceutical maintains a prevalent Real Value of W5362.88 per share. The last-minute price of the company is W6410.0. Our model calculates the value of Withuspharmaceutical from examining the company fundamentals such as Profit Margin of 0.12 %, return on asset of 0.0664, and Current Valuation of 101.14 B as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Withuspharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Withuspharmaceutical is based on 3 months time horizon. Increasing Withuspharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Withuspharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Withuspharmaceutical Stock. However, Withuspharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6410.0 | Real 5362.88 | Hype 6410.0 | Naive 6395.0 |
The real value of Withuspharmaceutical Stock, also known as its intrinsic value, is the underlying worth of Withuspharmaceutical Company, which is reflected in its stock price. It is based on Withuspharmaceutical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Withuspharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Withuspharmaceutical CoLtd helps investors to forecast how Withuspharmaceutical stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Withuspharmaceutical more accurately as focusing exclusively on Withuspharmaceutical's fundamentals will not take into account other important factors: Withuspharmaceutical Total Value Analysis
Withuspharmaceutical CoLtd is presently estimated to have takeover price of 101.14 B with market capitalization of 122.03 B, debt of 8.99 B, and cash on hands of 13.83 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Withuspharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
101.14 B | 122.03 B | 8.99 B | 13.83 B |
Withuspharmaceutical Investor Information
About 56.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Withuspharmaceutical had 3:2 split on the 11th of June 2021. Withuspharmaceutical CoLtd is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Withuspharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Withuspharmaceutical has an asset utilization ratio of 48.26 percent. This suggests that the Company is making W0.48 for each dollar of assets. An increasing asset utilization means that Withuspharmaceutical CoLtd is more efficient with each dollar of assets it utilizes for everyday operations.Withuspharmaceutical Ownership Allocation
The market capitalization of Withuspharmaceutical is W122.03 Billion. Withuspharmaceutical owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the company is less than the current market value, you may not be able generate positive returns on investment in the long run.Withuspharmaceutical Profitability Analysis
The company reported the revenue of 57.42 B. Net Income was 4.26 B with profit before overhead, payroll, taxes, and interest of 32.33 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Withuspharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Withuspharmaceutical and how it compares across the competition.
About Withuspharmaceutical Valuation
The stock valuation mechanism determines Withuspharmaceutical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Withuspharmaceutical. We calculate exposure to Withuspharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Withuspharmaceutical's related companies.Withus Pharmaceutical Co., Ltd. produces and sells pharmaceutical products in South Korea. The company was founded in 2005 and is headquartered in Seoul, South Korea. Withus Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct Withuspharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Withuspharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Withuspharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Withuspharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Withuspharmaceutical's revenue streams: Identify Withuspharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Withuspharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Withuspharmaceutical's growth potential: Evaluate Withuspharmaceutical's management, business model, and growth potential.
- Determine Withuspharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Withuspharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Withuspharmaceutical Stock analysis
When running Withuspharmaceutical's price analysis, check to measure Withuspharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Withuspharmaceutical is operating at the current time. Most of Withuspharmaceutical's value examination focuses on studying past and present price action to predict the probability of Withuspharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Withuspharmaceutical's price. Additionally, you may evaluate how the addition of Withuspharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |